Dillon Clarey is a Dermatology physician affiliated with University of Nebraska Medical Center. OpenAlex indexes 44 publications with 363 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4508 38th St Ste 210
Columbus, NE 686011668
Telephone
402-562-4871Provider last certified this registry record 10 Sept 2023.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20256 payments
- Lilly USA, LLCProgram year202510 payments
- Regeneron Healthcare Solutions, Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
37.3%Azole Antifungal20.1%Ketoconazole100%Part D≥122 patientsFirst-generation cephalosporins5.5%Cefadroxil100%Part D≥48 patients+ 4 more classes in this area
Dermatology
23.7%Corticosteroid19.3%Triamcinolone Acetonide100%Part D≥130 patientsAzole Antifungal2.3%Clotrimazole100%Part D≥13 patients+ 1 more class in this area
Sensory organs
23.6%Corticosteroid22.3%Clobetasol Propionate51%Hydrocortisone49%Part D≥80 patientsAminoglycoside Antibacterial1.3%Gentamicin Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Disparities in melanoma outcomes in urban versus rural settings: An analysis from the Nebraska cancer registry 2001-2016
Journal of the American Academy of Dermatology
2023 - Trichodysplasia Spinulosa related to Ruxolitinib: A Case Report
Graduate Medical Education Research Journal
2023
Similar KOLs
Other experts from the same institution or the same specialty.
James Armitage, MD
University of Nebraska Medical Center
Julie Vose, MD
University of Nebraska Medical Center
Kathleen Moore, MD
University of Nebraska Medical Center
Ted Mikuls, MD
University of Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”